Faneli Adriano Cypriano, Amaral Dillan Cunha, Menezes Isabelle Rodrigues, Marques Guilherme Nunes, Guedes Jaime, Brazuna Rodrigo, Oliveira Ricardo Danilo Chagas, Muccioli Cristina
Bahiana School of Public Health and Medicine, Av. Dom João, 275, Salvador, BA, 40290-000, Brazil.
Faculty of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
J Ophthalmic Inflamm Infect. 2025 Mar 17;15(1):29. doi: 10.1186/s12348-025-00486-6.
To assess the prevalence of ocular findings in patients with psoriasis and compare the odds of developing these conditions between the psoriatic and control population through a systematic review and meta-analysis.
A comprehensive literature search was conducted using PubMed, Embase, Cochrane, and Web of Science databases to identify studies reporting ocular findings in psoriasis patients. Inclusion criteria encompassed cross-sectional, case-control, cohort studies, case series, and case studies. Data extraction and quality assessment followed PRISMA guidelines. The Newcastle-Ottawa Scale evaluated the risk of bias. Heterogeneity was assessed using Cochran's Q-test and I² statistics, with a random-effects model applied where significant heterogeneity was present.
30 studies comprising 131,687 patients (13,788 with psoriasis and 117,899 controls) were included. The relative likelihood of ocular findings in psoriasis patients showed to be increased in conjunctival hyperemia (OR = 7.38; 95% CI: 2.47-22.04), conjunctivitis (OR = 4.63; 95% CI: 1.42-15.08), dry eye (OR = 3.47; 95% CI: 2.06-5.83), and meibomian gland dysfunction (OR = 7.13; 95% CI: 2.14-23.72) compared to controls. In contrast, blepharitis, cataracts, episcleritis, glaucoma, pinguecula, pterygium, and uveitis did not differ significantly between the two groups.
Psoriasis patients are at increased risk for certain ocular conditions, particularly conjunctival hyperemia, conjunctivitis, dry eye, and meibomian gland dysfunction. Further research is needed to understand the underlying mechanisms and to develop targeted management strategies.
通过系统评价和荟萃分析,评估银屑病患者眼部病变的患病率,并比较银屑病患者与对照组发生这些病变的几率。
使用PubMed、Embase、Cochrane和Web of Science数据库进行全面的文献检索,以确定报告银屑病患者眼部病变的研究。纳入标准包括横断面研究、病例对照研究、队列研究、病例系列和病例报告。数据提取和质量评估遵循PRISMA指南。采用纽卡斯尔-渥太华量表评估偏倚风险。使用Cochran's Q检验和I²统计量评估异质性,存在显著异质性时应用随机效应模型。
纳入30项研究,共131,687例患者(13,788例银屑病患者和117,899例对照)。与对照组相比,银屑病患者出现结膜充血(OR = 7.38;95% CI:2.47 - 22.04)、结膜炎(OR = 4.63;95% CI:1.42 - 15.08)、干眼(OR = 3.47;95% CI:2.06 - 5.83)和睑板腺功能障碍(OR = 7.13;95% CI:2.14 - 23.72)的相对可能性增加。相比之下,睑缘炎、白内障、巩膜炎、青光眼、睑裂斑、翼状胬肉和葡萄膜炎在两组之间无显著差异。
银屑病患者患某些眼部疾病的风险增加,尤其是结膜充血、结膜炎、干眼和睑板腺功能障碍。需要进一步研究以了解其潜在机制并制定针对性的管理策略。